
CERO Therapeutics Holdings, Inc.
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
Stock Performance (90 Days)
Layoff History
Recent News
Other Biotechnology Companies
View All →Frequently Asked Questions
Has CERO THERAPEUTICS HOLDINGS, INC. had layoffs?
How many employees does CERO THERAPEUTICS HOLDINGS, INC. have?
What industry is CERO THERAPEUTICS HOLDINGS, INC. in?
Is CERO THERAPEUTICS HOLDINGS, INC. a publicly traded company?
Where is CERO THERAPEUTICS HOLDINGS, INC. headquartered?
Disclaimer
Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.
This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.
Found an error? Report it here.